Search
for
Sort by
Research 61–90 of 1000+
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- The antimycotic agent clotrimazole inhibits melanogenesis by accelerating ERK and PI3K-/Akt-mediated tyrosinase degradation
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- The Transmembrane Serine Protease HAT-like 4 Is Important for Epidermal Barrier Function to Prevent Body Fluid Loss
- Differential plasma proteome analysis reveals key proteins associated with insulin resistance in acne vulgaris patients
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Protease-Activated Receptor-1 (Thrombin Receptor) Is Expressed in Mesenchymal Portions of Human Hair Follicle
- Cutaneous drug reactions
- Lysocellin, a metabolite of the novel drug ‘alopestatin’, induces G1 arrest and prevents cytotoxicity induced by etoposide
- The dark and the bright sides of the transcription factor Nrf2 in skin protection and disease (Nrf2 and epidermal barrier function)
- The CAP1/Prss8 catalytic triad is not involved in PAR2 activation and protease nexin‐1 (PN‐1) inhibition
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- A 20-year retrospective clinicopathologic study on melanoma in Singapore
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Enzyme Inhibitors from Gorgonians and Soft Corals
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- The fiber diameter traits of Tibetan cashmere goats are governed by the inherent differences in stress, hypoxic, and metabolic adaptations: an integrative study of proteome and transcriptome
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Plakophilin 1 suppresses keratinocyte innate immune responses through DExD/H helicases
- Wound Healing: A Cellular Perspective
- Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231
- Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and In Vivo Evidence